Lora Talley Watts Selected Research

methylthio-ADP

4/2013	P2Y1R-initiated, IP3R-dependent stimulation of astrocyte mitochondrial metabolism reduces and partially reverses ischemic neuronal damage in mouse.
1/2013	Purinergic 2Y1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lora Talley Watts Research Topics

Disease

3	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2016 - 07/2015
2	Edema (Dropsy) 07/2015 - 01/2013
2	Gliosis 07/2015 - 01/2013
2	Stroke (Strokes) 06/2015 - 04/2013
1	Mitochondrial Diseases (Mitochondrial Disease) 10/2017
1	Brain Injuries (Brain Injury) 10/2017
1	Brain Concussion (Cerebral Concussion) 06/2014
1	Brain Infarction 04/2013
1	Wounds and Injuries (Trauma) 01/2013
1	Brain Edema (Cerebral Edema) 01/2013

Drug/Important Bio-Agent (IBA)

3	Methylene Blue (Methylthioninium Chloride)FDA Link 10/2017 - 06/2014
2	Glial Fibrillary Acidic ProteinIBA 07/2015 - 01/2013
2	methylthio-ADPIBA 04/2013 - 01/2013
2	Purinergic Receptors (Receptors, Purine)IBA 04/2013 - 01/2013
1	Oxygen (Dioxygen)IBA 07/2015
1	CalciumIBA 07/2015
1	ManganeseIBA 07/2015
1	Neuroprotective AgentsIBA 07/2015
1	Rose BengalIBA 06/2015
1	Aquaporins (Water Channels)IBA 01/2013
1	(N)-methanocarba-2MeSADPIBA 01/2013
1	Diphosphates (Pyrophosphates)IBA 01/2013